Stallion India Fluorochemicals Ltd

Stallion India Fluorochemicals (SIFL) has received approval from RIICO for allotment of land for its proposed Hydrofluoroolefin (HFO) manufacturing plant at the RIICO Industrial Area, Ukhalliya, District Bhilwara, Rajasthan. The company plans to invest approximately Rs 200 crore in the project with start of work planned in 2027. The project will also be eligible for incentives under RIPS-2024, including capex linked benefits that, through a combination of subsidies such as SGST-linked incentives, capital and performance-linked support, interest subvention, and employment-linked benefits. Powered by Capital Market - Live

Stallion India Fluorochemicals will hold a meeting of the Board of Directors of the Company on 5 February 2026.Powered by Capital Market - Live

Net profit of Stallion India Fluorochemicals rose 13.80% to Rs 11.13 crore in the quarter ended December 2025 as against Rs 9.78 crore during the previous quarter ended December 2024. Sales rose 22.90% to Rs 104.65 crore in the quarter ended December 2025 as against Rs 85.15 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales104.6585.15 23 OPM %12.7516.82 - PBDT13.5112.59 7 PBT13.2112.29 7 NP11.139.78 14 Powered by Capital Market - Live

Stallion India Fluorochemicals (SIFL) has signed a Memorandum of Understanding (MoU) for cooperation and joint working with SYS ADVANCE, Portugal, for a technology tie-up covering advanced systems and equipment for Helium Recovery and Helium Liquefaction applications. SYS ADVANCE is a globally recognized industrial gas equipment manufacturer and a leading developer of containerised Helium Recovery Systems, with its technology qualified by European Space Agencies for space and high-end cryogenic applications. Powered by Capital Market - Live

Stallion India Fluorochemicals will hold a meeting of the Board of Directors of the Company on 29 January 2026.Powered by Capital Market - Live

The board of Stallion India Fluorochemicals at its meeting held on 23 January 2026 has approved to raise up to Rs 354 crore via rights issue. Powered by Capital Market - Live

Stallion India Fluorochemicals has postponed the meeting of the Board of Directors which was scheduled to be held on 21 January 2026. The meeting will now be held on 23 January 2026.Powered by Capital Market - Live

Stallion India Fluorochemicals will hold a meeting of the Board of Directors of the Company on 21 January 2026.Powered by Capital Market - Live

Stallion India Fluorochemicals has received environmental clearance from the State Environment Impact Assessment Aulhomy (SEIAA), Rajasthan, for proposed R-32 obtained manufacturing plant with an approved capacity of 10,000 MT per annum, generation of Hydrochloric Acid (HCI - 30%) as a by-product with a capacity of 46,460 MT per annum, and manufacture of non-EC blended refrigerants including R-410A, R-407C, R- 404A, R-507A, R-454B, R-513A, R-515B, R-449A and R-448A with an aggregate capacity of 7,500 MT per annum, at Plot No. SP3-10, RIICO Industrial Area, Ukhaliya, Tehsil - Hurda, District - Bhilwara, Rajasthan. Powered by Capital Market - Live

In a press release, the company said the promoter sold 16,20,987 shares worth Rs 45.74 crore and will infuse the entire amount back into the company on an interest-free basis. The funds are intended to ensure timely commencement of groundwork and construction for the upcoming R-32 facility. The company clarified that the infusion would be made without any equity dilution. Managing director and CEO Shazad Rustomji said the move demonstrates his personal commitment to advancing the company's self-reliance goals in the fluorochemicals manufacturing segment. This infusion ensures work on our R-32 project begins without delay, while maintaining our capital structure, he noted. Stallion India Fluorochemicals is a specialized leader in the refrigerants and industrial gases sector. It is engaged in processing, blending, and distributing gases across diverse industries including air conditioning, refrigeration, fire-fighting, semiconductor manufacturing, pharmaceuticals, automotive, and glass production. The company operates four strategic manufacturing facilities located in Khalapur, Ghiloth, Manesar, and Panvel, specializing in the debulking, blending, and processing of gases. The company reported a net profit of Rs 11.41 crore in Q2 FY26, a sharp rise from Rs 0.85 crore in Q2 FY25. Revenue grew 56.3% year-on-year to Rs 105.56 crore, while EBITDA surged to Rs 15.77 crore from Rs 2.35 crore a year ago. Profit before tax stood at Rs 15.24 crore, compared with Rs 0.55 crore in the same quarter last year. The stock debuted on the bourses on 23 January 2025, listing at Rs 120, a premium of 33.33% over the issue price of Rs 90. The initial public offer (IPO) of Stallion India Fluorochemicals was subscribed 188.38 times. The issue was open for bidding from 16 to 20 January 2025, with a price band fixed between Rs 85 and Rs 90 per share. The stock hit a record high of Rs 424.20 on 17 October 2025. Since then, it has been on a downward spiral, declining 41.62% to the current level. Powered by Capital Market - Live